eGnome has signed an agreement with Samarkand State Medical University in Uzbekistan to establish a K-Bio Innovation Center. Through this partnership, EGnome plans to set up a local corporation to provide premium medical services and conduct clinical trials, while also supporting the transfer of advanced medical technology and joint research. In particular, EGnome aims to deliver region-specific medical solutions, including precision medicine services and prenatal genetic testing, with the goal of innovating the healthcare ecosystem in Central Asia.

eGnome CEO Seo-ae Cho expressed her vision, stating, "Based on our long-term partnership with Samarkand State Medical University, we aim to establish a new hub in Asia for premium medical services and clinical trial management."